ConforMIS Inc. (NASDAQ:CFMS) saw strong trading volume on Monday . 519,043 shares changed hands during trading, an increase of 62% from the previous session’s volume of 321,031 shares.The stock last traded at $8.93 and had previously closed at $8.18.

A number of research analysts have commented on CFMS shares. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $12.00 target price (down previously from $18.00) on shares of ConforMIS in a research note on Tuesday, May 17th. Zacks Investment Research upgraded ConforMIS from a “sell” rating to a “hold” rating in a research note on Wednesday, June 1st. Wells Fargo & Co. downgraded ConforMIS from an “outperform” rating to a “market perform” rating in a research note on Friday, May 13th. Deutsche Bank AG lowered their target price on ConforMIS from $26.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, May 13th. Finally, JPMorgan Chase & Co. lowered their target price on ConforMIS from $11.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 9th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. ConforMIS presently has a consensus rating of “Buy” and a consensus price target of $15.40.

The company’s market capitalization is $384.15 million. The firm has a 50 day moving average price of $7.25 and a 200 day moving average price of $8.98.

ConforMIS (NASDAQ:CFMS) last posted its quarterly earnings results on Monday, August 8th. The company reported ($0.34) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.35) by $0.01. During the same period last year, the company earned ($2.51) EPS. The company earned $19.30 million during the quarter, compared to analyst estimates of $18.02 million. The business’s revenue for the quarter was up .5% compared to the same quarter last year. Equities analysts expect that ConforMIS Inc. will post ($1.41) EPS for the current fiscal year.

A hedge fund recently raised its stake in ConforMIS stock. RS Investment Management Co. LLC raised its stake in ConforMIS Inc. (NASDAQ:CFMS) by 3.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,432,470 shares of the company’s stock after buying an additional 43,490 shares during the period. RS Investment Management Co. LLC owned 3.52% of ConforMIS worth $24,767,000 at the end of the most recent quarter.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.